May TGFBR1 act also as low penetrance allele in Marfan syndrome?

International Journal of Cardiology

Volumn 131, Issue 2, 2009, Pages 281-284

  Lucarini, Laura ^a   Evangelisti, Lucia ^a   Attanasio, Monica ^a   Lapini, Ilaria ^a   Chiarini, Francesca ^a   Porciani, Maria Cristina ^a   Abbate, Rosanna ^a   Gensini, GianFranco ^a,b   Pepe, Guglielmina ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Marfan syndrome; MFS type 2; TGFBR1; TGFBR1 6Ala allele

Indexed keywords

FIBRILLIN 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

5' UNTRANSLATED REGION; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HUMAN; MALE; MARFAN SYNDROME; PENETRANCE; PHENOTYPE; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; ALLELES; BASE SEQUENCE; CHILD; FEMALE; GENETIC MARKERS; GENETIC VARIATION; HUMANS; MALE; MARFAN SYNDROME; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PENETRANCE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; YOUNG ADULT;

EID: 57649115719     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.07.048     Document Type: Article

References (14)

1. Judge D.P., and Dietz H.C. Marfan's syndrome. Lancet 366 (2005) 1965-1976
2. Collod-Beroud G., Le Bourdelles S., Ades L., et al. Update of the UMD-FBN1 mutation database and creation of an FBN1 polymorphism database. Hum Mutat 22 (2003) 199-208
3. Mizuguchi T., Collod-Beroud G., Akiyama T., et al. Heterozygous TGFBR2 mutations in Marfan syndrome. Nat Genet 36 (2004) 855-860
4. Matyas G., Arnold E., Carrel T., et al. Identification and in silico analyses of novel TGFBR1 and TGFBR2 mutations in Marfan syndrome-related disorders. Hum Mutat 27 (2006) 760-769
5. Singh K.K., Rommel K., Mishra A., et al. TGFBR1 and TGFBR2 mutations in patients with features of Marfan syndrome and Loeys-Dietz syndrome. Hum Mutat 27 (2006) 770-777
6. Lu S.L., Kawabata M., Imamura T., Miyazono K., and Yuasa Y. Two divergent signaling pathways for TGF-beta separated by a mutation of its type II receptor gene. Biochem Biophys Res Commun 259 (1999) 385-390
7. Pannu H., Fadulu V.T., Chang J., et al. Mutations in transforming growth factor-beta receptor type II cause familial thoracic aortic aneurysms and dissections. Circulation 112 (2005) 513-520
8. Loeys B.L., Chen J., Neptune E.R., et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 37 (2005) 275-281
9. Loeys B.L., Schwarze U., Holm T., et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 355 (2006) 788-798
10. Habashi J.P., Judge D.P., Holm T.M., et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312 (2006) 117-121
11. Pepe G., Giusti B., Evangelisti L., et al. Fibrillin-1 (FBN1) gene frameshift mutations in Marfan patients: genotype-phenotype correlation. Clin Genet 59 (2001) 444-450
12. Giusti B., Lucarini L., Pietroni V., et al. Dominant and recessive COL6A1 mutations in Ullrich scleroatonic muscular dystrophy. Ann Neurol 58 (2005) 400-410
13. Pasche B., Luo Y., Rao P.H., et al. Type I transforming growth factor beta receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract. Cancer Res 58 (1998) 2727-2732
14. Pasche B., Knobloch T.J., Bian Y., et al. Somatic acquisition and signaling of TGFBR1*6A in cancer. JAMA 294 (2005) 1634-1646